Accenture (NYSE:ACN - Get Free Report) issued an update on its FY 2025 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 12.770-12.890 for the period, compared to the consensus estimate of 12.750. The company issued revenue guidance of $68.8 billion-$69.4 billion, compared to the consensus revenue estimate of $68.8 billion. Accenture also updated its Q4 2025 guidance to EPS.
Accenture Trading Down 1.9%
Shares of ACN stock opened at $306.11 on Friday. Accenture has a fifty-two week low of $275.01 and a fifty-two week high of $398.35. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.48 and a current ratio of 1.48. The stock's fifty day moving average is $306.94 and its two-hundred day moving average is $334.32. The firm has a market capitalization of $191.72 billion, a P/E ratio of 25.28, a PEG ratio of 3.09 and a beta of 1.33.
Accenture (NYSE:ACN - Get Free Report) last posted its quarterly earnings results on Friday, June 20th. The information technology services provider reported $3.49 earnings per share for the quarter, topping the consensus estimate of $3.27 by $0.22. Accenture had a net margin of 11.43% and a return on equity of 26.49%. During the same period in the prior year, the company earned $3.13 EPS. Research analysts expect that Accenture will post 12.73 earnings per share for the current fiscal year.
Accenture Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Thursday, July 10th will be issued a $1.48 dividend. This represents a $5.92 annualized dividend and a dividend yield of 1.93%. Accenture's dividend payout ratio is presently 48.89%.
Analysts Set New Price Targets
ACN has been the topic of a number of recent research reports. Piper Sandler lowered their price objective on Accenture from $364.00 to $355.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Benchmark reissued a "mixed" rating on shares of Accenture in a research report on Friday. Stifel Nicolaus cut their price objective on shares of Accenture from $390.00 to $380.00 and set a "buy" rating for the company in a research report on Wednesday, February 26th. BMO Capital Markets increased their price target on shares of Accenture to $355.00 and gave the company a "hold" rating in a research note on Wednesday, March 26th. Finally, Baird R W raised shares of Accenture from a "hold" rating to a "strong-buy" rating in a research report on Monday, March 17th. Seven equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $380.00.
Check Out Our Latest Research Report on Accenture
Insider Activity at Accenture
In other Accenture news, CEO Julie Spellman Sweet sold 2,284 shares of the stock in a transaction that occurred on Friday, April 11th. The shares were sold at an average price of $281.63, for a total transaction of $643,242.92. Following the sale, the chief executive officer now directly owns 9,965 shares in the company, valued at $2,806,442.95. This represents a 18.65% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO John F. Walsh sold 2,500 shares of the company's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $325.00, for a total value of $812,500.00. Following the sale, the chief operating officer now directly owns 15,882 shares in the company, valued at $5,161,650. This represents a 13.60% decrease in their position. The disclosure for this sale can be found here. Insiders sold 8,516 shares of company stock worth $2,507,366 in the last three months. 0.02% of the stock is owned by company insiders.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Accenture stock. Brighton Jones LLC boosted its holdings in Accenture PLC (NYSE:ACN - Free Report) by 36.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 18,438 shares of the information technology services provider's stock after buying an additional 4,905 shares during the quarter. Brighton Jones LLC's holdings in Accenture were worth $6,486,000 at the end of the most recent quarter. Institutional investors and hedge funds own 75.14% of the company's stock.
Accenture Company Profile
(
Get Free Report)
Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management; intelligent automation comprising robotic process automation, natural language processing, and virtual agents; and application management services, as well as software engineering services; strategy and consulting services; data and analytics strategy, data discovery and augmentation, data management and beyond, data democratization, and industrialized solutions comprising turnkey analytics and artificial intelligence (AI) solutions; metaverse; and sustainability services.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Accenture, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Accenture wasn't on the list.
While Accenture currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.